Screener
Veradermics MANE Business Segments — Investment accretion
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Veradermics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 5:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001827635-26-000019
(1) For the three months ended March 31, 2026 other segment items include interest income of $2.5 million and investment accretion of $0.1 million. For the three months ended March 31, 2025, other segment items include interest income of $0.5 million.
Item 1. Condensed Consolidated Financial Statements (
FAQ
- What is Veradermics's business segments — investment accretion?
- Veradermics (MANE) reported business segments — investment accretion of $100K in Q1 2026.
- How has Veradermics's business segments — investment accretion changed year-over-year?
- Veradermics's business segments — investment accretion increased by 669.2% year-over-year, from $13K to $100K.
- What does business segments — investment accretion mean?
- This metric represents the non-cash increase in the value of the company's investment portfolio, typically resulting from the amortization of discounts on debt securities. It reflects the gradual realization of value from investments held at a discount to their face value. This is a non-operating financial item that impacts the company's reported net income.
Ask your AI about Veradermics's business segments — investment accretion.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude